Access Resources
2371 - 2380 of 7540 Results
Title
Year
- Sex differences in brain atrophy and cognitive impairment in Parkinson’s disease patients with and without probable rapid eye movement sleep behavior disorder2021RESTRICTEDTitle: Sex differences in brain atrophy and cognitive impairment in Parkinson’s disease patients with and without probable rapid eye movement sleep behavior disorderJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 269Issue #: 3Start Page: 1591End Page: 1599Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1007/s00415-021-10728-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-021-10728-x.pdfCitation Count: 20
-
RESTRICTEDTitle: A Call to Action: Promoting Diversity, Equity, and Inclusion in Parkinson’s Research and CareJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 11Issue #: 3Start Page: 905End Page: 908Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212593Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212593?id=journal-of-parkinsons-disease%2Fjpd212593Citation Count: 17
- Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disorders2021RESTRICTEDTitle: Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disordersJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 93Issue #: 1Start Page: 24End Page: 31Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2021-326904Best OA location URL: https://hal.sorbonne-universite.fr/hal-03471111/documentCitation Count: 55
-
RESTRICTEDTitle: Assessing the Quality and Reliability of COVID-19 Information on Patient Organization WebsitesJournal Name: Frontiers in CommunicationPublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcomm.2021.716683Best OA location URL: https://www.frontiersin.org/articles/10.3389/fcomm.2021.716683/pdfCitation Count: 3
- Constipation is Associated with Development of Cognitive Impairment in de novo Parkinson’s Disease: A Longitudinal Analysis of Two International Cohorts2021RESTRICTEDTitle: Constipation is Associated with Development of Cognitive Impairment in de novo Parkinson’s Disease: A Longitudinal Analysis of Two International CohortsJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 11Issue #: 3Start Page: 1209End Page: 1219Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-212570Citation Count: 29
- Contribution of Basal Ganglia to the Sense of Upright: A Double-Blind Within-Person Randomized Trial of Subthalamic Stimulation in Parkinson’s Disease with Pisa Syndrome2021RESTRICTEDTitle: Contribution of Basal Ganglia to the Sense of Upright: A Double-Blind Within-Person Randomized Trial of Subthalamic Stimulation in Parkinson’s Disease with Pisa SyndromeJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 11Issue #: 3Start Page: 1393End Page: 1408Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-202388Citation Count: 3
- Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic Efficacy2021RESTRICTEDTitle: Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic EfficacyJournal Name:Publisher:Vol:Issue #:Start Page: 1306End Page: 1321Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acsptsci.0c00162;Citation Count: 9
- Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic Efficacy2021RESTRICTEDTitle: Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic EfficacyJournal Name: ACS Pharmacology & Translational SciencePublisher: American Chemical Society (ACS)Vol: 4Issue #: 4Start Page: 1306End Page: 1321Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acsptsci.0c00162Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369681Citation Count: 10
- Disentangling the PIGD classification for the prediction of cognitive impairment in de novo Parkinson’s disease2021RESTRICTEDTitle: Disentangling the PIGD classification for the prediction of cognitive impairment in de novo Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 269Issue #: 3Start Page: 1566End Page: 1573Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-021-10730-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-021-10730-3.pdfCitation Count: 4
- Early-Onset Parkinsonism and Early-Onset Parkinson’s Disease: A Population-Based Study (2010-2015)2021RESTRICTEDTitle: Early-Onset Parkinsonism and Early-Onset Parkinson’s Disease: A Population-Based Study (2010-2015)Journal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 11Issue #: 3Start Page: 1197End Page: 1207Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-202464Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355040Citation Count: 29